Konferencja Naukowa 2023

Konferencja Naukowa 2023

 

GENETYKA KLINICZNA NOWOTWORÓW 2023

      CLINICAL GENETICS OF CANCER 2023

 

 

Programme of the International Conference CLINICAL GENETICS OF CANCER (download)

Dear Colleagues,

We would like to thank all participants for taking part in the International Conference „Clinical Genetics of Cancer 2023”.

We invite you to participate in the Scientific Conference next year.

ABSTRAKTY

Abstrakt 1. Scott Rodney – Are there germline genetic variants that correlate with mutational events in adult brain tumours?

Abstrakt 2. Hemminki Kari – Germline genetics of familial cancer

Abstrakt 3. Försti Asta – Germline variants in cancer patients with personal and family history of colorectal cancer

Abstrakt 4. Bisseling Tanya – Hereditary diffuse type gastric cancer: CDH1 – An update and a glimpse of preliminary science

Abstrakt 5. Nowakowska Dorota – HDGC (Hereditary Diffuse Gastric Cancer) – challenges of care- preliminary Polish results

Abstrakt 6. Irmejs Arvids – Early Insights from Hereditary Breast and Ovarian Cancer Risk Genetic Screening Pilot in Latvia

Abstrakt 7. Elsakov Pavel – Mirror results in population screening of Breast and Colorectal cancer in Lithuania.

Abstrakt 8. Vodicka Pavel Genomic instability, microenvironment and telomere homeostasis in solid malignancies

Abstrakt 9. Pławski Andrzej – c.268G>A substitution in NTHL1 gene in Polish polyposis patients

Abstrakt 10. Baszuk Piotr – Blood copper and arsenic levels and the occurrence of colorectal cancer

Abstrakt 11. Grzybowska Ewa –  Genetic polymorphisms, response to treatment and adverse effects in breast cancer patients treated with FAC chemotherapy

Abstrakt 12. Bińkowski Jan – Different histological types of breast cancer share common epigenetic and transcriptomic signature that predicts clinical outcome

Abstrakt 13. Wojdacz Tomasz –  Detection of constitutional epimutation of BRCA1is only possible with highly sensitive method

Abstrakt 14. Taryma-Leśniak Olga –  Genomes of BRCA1 mutation and epimutation carriers appear to acquire specific epigenetic signature

Abstrakt 15. Przybyłowicz Patrycja – Epigenetic age of female BRCA1 mutation carriers appears not to be correlated with their chronological age

Abstrakt 16. Siwiec Ewa – DMSA in lowering blood Pb cancerogenic level

Abstrakt 17. Szwiec Marek – Ratio of blood Zn/Cu levels as a marker of survival in breast cancer patients

Abstrakt 18. Pietrzak Sandra –  Serum Essential Elements and Survival after Cancer Diagnosis

Abstrakt 19. Matuszczak Milena – Correlation between Se, Zn levels and survival among prostate cancer patients

Abstrakt 20. Cybulski Cezary – Mutations in the ATRIP gene predispose to breast cancer

Abstrakt 21. Mądry Radosław – The place of genetic testing in the treatment of endometrial cancer – consequence of the TCGA Molecular Classification and the new drugs

Abstrakt 22. Mądry Radosław – Simultaneous risk reduction surgery – mastectomy and adnexectomy – a new treatment option for BRCA mutation carriers – a win-win strategy for everyone

Abstrakt 23. Heise Marta – Clinical significance of germline variants in ASXL1, CHD1, IDH1, SETD2 and TET2 epigenetic genes and their association with prostate cancer risk in Polish men – preliminary results

Abstrakt 24. Bąk Aneta – Germline mutations associated with acute myeloid leukemia

Abstrakt 25. Kałużewski Bogdan – Propozycja zmiany osi czasu w aplikacji badań genetycznych w raku stercza. Wykorzystanie przezkroczowej biopsji fuzyjnej, jako narzędzia pozwalającego na uzyskanie materiału diagnostycznego



 adres e-mail: konferencjanowotworydziedziczne@wp.pl.

 

Najnowsze wpisy